Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model (2015)
Stefano, José Tadeu; Pereira, Isabel Veloso Alves; Torres, M. M; Bida, P. M; Coelho, A. M. M; Xerfan, M. P; Cogliati, Bruno 
; Barbeiro, Denise Frediani; Mazo, Daniel Ferraz de Campos; Kubrusly, Marcia Saldanha; D’Albuquerque, L. A. C; Souza, Heraldo Possolo de; Carrilho, Flair José; Oliveira, Cacilda Pedrosa de
Fonte: Brazilian Journal of Medical and Biological Research. Unidades: FMVZ, FM
Assuntos: ANTINEOPLÁSICOS, HEPATOPATIAS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEFANO, José Tadeu et al. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Brazilian Journal of Medical and Biological Research, v. 48, n. 5, p. 408-414, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20143962. Acesso em: 03 nov. 2024.APA
Stefano, J. T., Pereira, I. V. A., Torres, M. M., Bida, P. M., Coelho, A. M. M., Xerfan, M. P., et al. (2015). Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Brazilian Journal of Medical and Biological Research, 48( 5), 408-414. doi:10.1590/1414-431X20143962NLM
Stefano JT, Pereira IVA, Torres MM, Bida PM, Coelho AMM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF de C, Kubrusly MS, D’Albuquerque LAC, Souza HP de, Carrilho FJ, Oliveira CP de. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 408-414.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/1414-431X20143962Vancouver
Stefano JT, Pereira IVA, Torres MM, Bida PM, Coelho AMM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF de C, Kubrusly MS, D’Albuquerque LAC, Souza HP de, Carrilho FJ, Oliveira CP de. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 408-414.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1590/1414-431X20143962
